Ovestin (Estriol)

Estriol, the active ingredient in Ovestin, is an estrogen hormone presented as a 0.5 mg/1 tablet for oral use. It treats menopausal symptoms and estrogen deficiency in women. GNH USA supplies Ovestin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Ovestin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Ovestin is an estrogen medication that acts on hormonal pathways related to menopause and estrogen deficiency.

- Menopausal vasomotor symptoms: Reduces frequency and severity of hot flashes. - Prevention of osteoporosis: Helps maintain bone mineral density. - Vaginal atrophy: Improves vaginal dryness and discomfort. - Hormone‑dependent cancer surveillance: Provides a controlled estrogen environment for monitoring. - Post‑menopausal hormone replacement: Supports overall hormonal balance.

Side effects vary with individual response and dosage.

Common Side Effects: - Nausea: Mild to moderate stomach upset. - Breast tenderness: Temporary swelling or discomfort. - Headache: Light‑to‑moderate pain. - Fluid retention: Slight swelling of ankles or feet. - Mood changes: Irritability or mild depression. - Vaginal spotting: Light bleeding between periods.

Serious or Rare Side Effects: - Thromboembolic events: Deep vein thrombosis or pulmonary embolism. - Stroke: Cerebrovascular accident risk. - Hepatic dysfunction: Elevated liver enzymes. - Endometrial hyperplasia: Abnormal uterine lining growth. - Allergic reaction: Rash, itching, or swelling. - Vision changes: Blurred or sudden loss of vision.

When prescribing Ovestin, clinicians should consider several safety aspects.

- Cardiovascular risk assessment: Evaluate history of clotting disorders. - Cancer surveillance: Monitor for estrogen‑sensitive malignancies. - Liver function: Check hepatic enzymes before initiation. - Bone health: Assess baseline bone mineral density. - Pregnancy and lactation: Contra‑indicated unless benefits outweigh risks. - Store at ambient temperature: Keep below 25 °C, in original packaging, protected from moisture.

Estradiol may interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants: May increase bleeding risk. - CYP3A4 inhibitors (e.g., ketoconazole): Elevate estradiol levels. - Aromatase inhibitors: Counteract estrogenic effects.

Moderate Interactions (Monitor Closely): - Anticonvulsants (e.g., phenytoin): Reduce estradiol efficacy. - Thyroid hormones: May alter hormone balance. - SSRIs/SNRIs: Potentially increase risk of serotonin syndrome. - Antihypertensives: May affect blood pressure control.